Citations 1
An Open-label Study Evaluating the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Tanruprubart Single Dose in Participants From North America and Europe With Guillain-Barré Syndrome (P3-19.004)
Ladha, Shafeeq, Grover, Kavita, Morrison, Glenn, Lin, Ping, Kroon, Henk‐André, Allen, Jeffrey, Ladha, Shafeeq , Mustafa, Rafid , Grover, Kavita Mohindra , Lin, Ping , Allen, Jeffrey
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
